Repairogen

About:

Repairogen employs proprietary DNA-repair technologies to create advanced, scientifically-proven skincare products.

Top Investors: Kairos Ventures, Big Red Ventures, Align Ventures, Brainchild Holdings, Joanne Wilson

Description:

Repairogen is developing premium anti-aging skincare ingredients and products based on a platform technology invented at an ivy-league medical research institution. Products incorporating its proprietary and scientifically proven technology will provide customers with healthier and younger-looking skin. It was founded in 2012 and headquartered in New York, United States.

Total Funding Amount:

$1.46M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New York, New York, United States

Founded Date:

2012-09-01

Contact Email:

info(AT)repairogen.com

Founders:

Frank Borchetta, Frederico Lourenco, Michael Boice

Number of Employees:

1-10

Last Funding Date:

2017-09-16

IPO Status:

Private

Industries: